Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
17-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
17-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #52349
advertisement
Gao H
5
Showing records 1 to 5 |
Display all abstracts from
Gao H
61594
Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Wei J
Journal of Molecular Neuroscience
2015; 57: 243-248
61552
Laser treatment of macular retinoschisis due to acquired optic nerve pit from glaucoma
Prinzi RA; Desai A
British Medical Journal (Clinical Research Edition) Case Reports
2015; 2015:
61594
Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Jiang H
Journal of Molecular Neuroscience
2015; 57: 243-248
61552
Laser treatment of macular retinoschisis due to acquired optic nerve pit from glaucoma
Gao H
British Medical Journal (Clinical Research Edition) Case Reports
2015; 2015:
61594
Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Gao H; Wang G
Journal of Molecular Neuroscience
2015; 57: 243-248
Issue
17-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept